Chinese Herbal Medicine Combined With First-Generation EGFR-TKIs in Treatment of Advanced Non-Small Cell Lung Cancer With EGFR Sensitizing Mutation: A Systematic Review and Meta-Analysis

Chinese Herbal Medicine Combined With First-Generation EGFR-TKIs in Treatment of Advanced Non-Small Cell Lung Cancer With EGFR Sensitizing Mutation: A Systematic Review and Meta-Analysis

Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. First-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) significantly improve prognosis of advanced NSCLC patients harboring EGFR sensitizing mutation. Howe...

Full description

Bibliographic Details
Main Authors: Yan Lu, Chenbing Sun, Lijing Jiao, Yu Liu, Yabin Gong, Ling Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pharmacology
Subjects:
chinese herbal medicine
non-small cell lung cancer (NSCLC)
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs)
meta-analysis
randomized controlled trials (RCT)
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.698371/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.698371/full

Similar Items